Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques.
We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
As one of the most significant herbs in Traditional Chinese Medicine (TCM), Má Huáng (Ephedra) has transitioned from ancient prescriptions to a cornerstone of modern botanical pharmaceuticals and industrial applications globally.
Current industrial trends show a 15% annual growth in demand for highly purified TCM granules. Pharmaceutical companies in Europe and North America are increasingly seeking standardized Má Huáng extracts for respiratory health and metabolic research under strict regulatory compliance.
In Southeast Asia, Má Huáng granules are a staple in seasonal flu clinics. In Western markets, our granules serve as a premium raw material for licensed practitioners who utilize the herb’s potent bronchodilator properties while ensuring the removal of impurities through our patented extraction processes.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation.
As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
We leverage advanced AI algorithms to monitor the extraction phase of Má Huáng, ensuring a 99.9% consistency in alkaloid concentration across every batch produced for export.
Every shipment of Má Huáng granules comes with a digital fingerprint analysis, ensuring the chemical profile matches the highest pharmacological standards for the medical industry.
Operating from our US subsidiary, Neo-Green Herbs INC, we handle localized warehousing and rapid distribution, lowering the barrier for international procurement by managing complex customs regulations for TCM components.
The global pharmaceutical industry is witnessing a paradigm shift toward "Modernized Herbal Medicine." For Má Huáng specifically, the focus has shifted from raw herb trade to Value-Added Extracts (VAE). As a leading manufacturer, Sichuan Neo-Green Pharmaceutical is at the forefront of this evolution. Our Má Huáng granules are designed to meet the growing 'Clean Label' trend, where medical institutions demand products free from heavy metals, pesticides, and sulfur fumigation.
Global enterprises are no longer just looking for a supplier; they are looking for a strategic manufacturing partner. By integrating AI-driven quality control and blockchain-traceable raw material sourcing, we offer the international market a level of transparency previously unseen in the TCM sector. Whether it is for a specialized clinic in California or a pharmaceutical lab in Berlin, our products provide the reliability required for modern clinical applications.
Neo-Green Herbs
